ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ) closed at $12.72 on October 19, 2026, up 3.00% on the day. The stock trades 13.4% below its 52-week high of $14.68 and 75.9% above its 52-week low of $7.23. Over the past year, it lost 3.4%. ORIC Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since October 17, 2025, ORIC closed higher on 117 days (46%). Its best day was August 4, 2026 (+27.08%) and its worst was April 1, 2026 (-41.00%). The stock moved 10% or more in a single session 12 times.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.
Find more stocks like ORIC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.